New Product Growth Drivers In Cold/Allergy/Sinus: Nothing To Sneeze At – IRI
This article was originally published in The Tan Sheet
Executive Summary
Sales of Mucinex DM and Sudafed PE helped drive OTC cold/allergy/sinus category sales up 11.4% to $2.7 bil. in 2005, according to Information Resources, Inc